Furthermore, individuals with TET2Mut CHIP exhibited significantly more advanced liver fibrosis and relatively higher levels of Ccl2 and Ccl8 in serum compared with TET2 WT (TET2WT) counterparts, even after adjusting for co-occurring mutations (Fig. 10, B–D). This evidence concerns the gene TET2 and Hepatic fibrosis.